Search Results - "Mizuta T"

Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.

Authors: Shirakawa T Makiyama A Shimokawa M et al.

Source: Scientific reports [Sci Rep] 2024 Mar 04; Vol. 14 (1), pp. 5311. Date of Electronic Publication: 2024 Mar 04.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; PubMed not MEDLINE

Predictors of prolonged progression-free survival in patients with unresectable or recurrent pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid (NAPOLEON-2 study).

Authors: Kawaguchi Y Hayashi K Shimokawa M et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2026 Apr 21; Vol. 18, pp. 17588359261442386. Date of Electronic Publication: 2026 Apr 21 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Author Index / Index des auteurs.

Source: Canadian Journal of Zoology. Dec2006, Vol. 84 Issue 12, pAI-1-AI-3. 3p.

Impact of prior chemotherapy on nanoliposomal irinotecan with fluorouracil and folinic acid for unresectable pancreatic cancer: a retrospective analysis of data from the multicenter NAPOLEON-2 study.

Authors: Koike T Kawaguchi Y Shimokawa M et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Nov 18; Vol. 17, pp. 17588359251393156. Date of Electronic Publication: 2025 Nov 18 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Impact of biliary drainage for unresectable pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid: retrospective results from the NAPOLEON-2 study.

Authors: Nishikawa K Otsuka T Shimokawa M et al.

Source: BMC cancer [BMC Cancer] 2025 Oct 21; Vol. 25 (1), pp. 1614. Date of Electronic Publication: 2025 Oct 21.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Trudinger-type inequalities in Musielak–Orlicz spaces over metric measure spaces.

Authors: Ohno, Takao Shimomura, Tetsu

Source: Georgian Mathematical Journal. Apr2026, Vol. 33 Issue 2, p289-299. 11p.

Effect of biliary drainage and biliary tract infection in unresectable pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid: a multicenter, prospective cohort study (NAPOLEON-2).

Authors: Yoshioka W Shirakawa T Shimokawa M et al.

Source: BMC cancer [BMC Cancer] 2026 May 26. Date of Electronic Publication: 2026 May 26.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Efficacy of third-line chemotherapy following nanoliposomal irinotecan combined with fluorouracil and folinic acid as second-line treatment for unresectable pancreatic cancer.

Authors: Miwa K Kawasaki R Shimokawa M et al.

Source: Frontiers in oncology [Front Oncol] 2025 Jul 17; Vol. 15, pp. 1626689. Date of Electronic Publication: 2025 Jul 17 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Microglia replacement halts the progression of microgliopathy in mice and humans.

Authors: Wu, Jingying Wang, Yafei Li, Xiaoyu et al.

Source: Science. 7/10/2025, Vol. 389 Issue 6756, p1-17. 17p.

Triple Asymmetric Transfer Hydrogenation of 2‐Arylidene‐1,3‐Indandiones.

Authors: Li, Jiaxin Tang, Jiahu Song, Hancheng et al.

Source: Advanced Science. 2/23/2026, Vol. 13 Issue 11, p1-12. 12p.

Migratory Strategies of Eurasian Sparrowhawk, Northern Goshawk, and Shikra Ringed in Kazakhstan.

Authors: Gavrilov, Andrey Akentyeva, Yekaterina Tashimova, Aizhan et al.

Source: Diversity (14242818). May2026, Vol. 18 Issue 5, p262. 14p.

Mechanistic molecular approaches to anti-gastric ulcer effects of Maesil Fruit (Prunus mume) in vivo.

Authors: Ahmed, Khaled Abdul-Aziz Alqaisi, Khalid M. Ibrahim, Noralhuda Ayad et al.

Source: Journal of King Saud University - Science. Apr2026, Vol. 38 Issue 4, p1-12. 12p.

Vitamin K2 Supplementation and Clinical Outcomes in Hepatocellular Carcinoma Patients: A Meta-Analysis with Trial Sequential Analysis.

Authors: de Moraes, Francisco Cezar Aquino Kendi Tsuchiya Sano, Vitor Pereira, Caroline R M et al.

Source: Nutrition & Cancer. 2026, Vol. 78 Issue 3, p208-220. 13p.

Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302).

Authors: Araki T Hayashi K Shimokawa M et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Feb 21; Vol. 17, pp. 17588359251320768. Date of Electronic Publication: 2025 Feb 21 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Clinical outcome of radiofrequency ablation in patients with hepatocellular carcinoma aged 80 years and older.

Authors: Takaura, Kenta Tsuchiya, Kaoru Taguchi, Mina et al.

Source: PLoS ONE. 10/14/2025, Vol. 20 Issue 10, p1-12. 12p.

Author Index.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2012 Supplement, Vol. 39, p640-682. 43p.

1999 Author index ? Volume 17.

Source: Nature Biotechnology. Jan2000, Vol. 18 Issue 1, p118. 4p.

Heterogeneity in Health-Related Quality of Life of Patients with Aplastic Anemia: A Latent Profile Analysis.

Authors: Wu, Guibin Li, Xiao Ren, Xiang et al.

Source: Patient Preference & Adherence. Mar2025, Vol. 18, p673-684. 12p.

Risk Factors and Long‐Term Prognosis for Coinfection of Nontuberculous Mycobacterial Pulmonary Disease and Chronic Pulmonary Aspergillosis: A Multicentre Observational Study in Japan.

Authors: Tanaka, Yasuhiro Ide, Shotaro Takazono, Takahiro et al.

Source: Mycoses. Jun2025, Vol. 68 Issue 6, p1-11. 11p.

Pemafibrate improves liver biochemistry and GLOBE scores in patients with primary biliary cholangitis: Nationwide, multicenter study by the Japanese Red Cross Liver Study Group.

Authors: Tsuji, Keiji Tamaki, Nobuharu Kurosaki, Masayuki et al.

Source: Hepatology Research. May2025, Vol. 55 Issue 5, p675-684. 10p.